UnitedHealthcare
Ayvakit (avapritinib)
Drugs for Cancer : Drugs for Cancer
  • Duration: 12 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: Yes
    Duration of Reauthorization: = 12 month(s)

  • Quantity Limit: limit maximum 1 EA PER 1 day(s)
  • Orally administered anticancer medication.
  • Prior Authorization: Documented Diagnosis: Yes
    Duration: 12 Month(s)
    Reauthorization Required: Yes